Nvidia’s and OpenAI’s data center plan is so massive that it is unclear whether they can secure the power capacity needed for it.
This Nvidia derivative is on the verge of a sharp move higher, according to the charts
Todd Gordon goes through the charts on this tech stock.
Nvidia’s big OpenAI investment lifted the whole market. It’s raising red flags about a bubble for many
Some veteran market watchers warn the deal is essentially vendor financing — Nvidia giving OpenAI money so OpenAI can turn around and spend it on Nvidia chips
A bullish options trade on this apparel giant that’s showing signs of a recovery
Nishant Pant breaks down this bull call spread options trade.
‘Animal spirits’ measure signals a market pullback could be near
A look under the surface of the S&P 500 may belies the benchmark continuing to run to fresh records.
Prediction markets for NFL and other events are already a $200 million business for Robinhood, says Piper Sandler
The investment firm, which has an overweight rating on Robinhood, raised its price target on the stock.
Asset manager Brookfield just struck a deal that will give it an edge in AI, analysts say
“We see scope for humanoid robots to increase operating margins of portfolio companies across the Brookfield ecosystem,” Morgan Stanley said.
The generational opportunity in muni bonds is ‘slipping away’ as yields fall and supply dwindles, strategist says
Investors who want to snap up attractive income on municipal bonds may not want to wait much longer, according to strategist Tom Kozlik.
Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher
Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market.
The charts on this telehealth stock point to strong gains ahead, according to Katie Stockton
Katie Stockton breaks down the technical outlook on this telehealth name.